Who owns REGULUS THERAPEUTICS INC?
- Ticker: RGLS
- CUSIP Number: 75915k309
Tip: Access positions for across all investors
Analyze quarterly positions in Regulus Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Regulus Therapeutics stock
Who bought or sold REGULUS THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Federated Investors | 13M | $20M | 0% | Sep 2024 |
|
| NEA Management Company | 6.5M | $10M | 100% | Sep 2024 |
|
| Octagon Capital Advisors | 4.3M | $6.7M | 0% | Sep 2024 |
|
| BlackRock | 4.1M | $6.4M | 100% | Sep 2024 |
|
| Vanguard Group | 4.1M | $7.2M | 447% | Jun 2024 |
|
| BlackRock | 4.0M | $7.1M | 5734% | Jun 2024 |
|
| Deep Track Capital | 3.3M | $5.8M | 0% | Jun 2024 |
|
| T. Rowe Price Associates | 2.2M | $3.4M | 10448% | Sep 2024 |
|
| Geode Capital Management | 1.3M | $2.0M | -4% | Sep 2024 |
|
| Alyeska Investment Group | 1.0M | $1.6M | 11% | Sep 2024 |
|
| State Street Corporation | 968k | $1.7M | 2219% | Jun 2024 |
|
| Woodline Partners | 949k | $1.5M | 0% | Sep 2024 |
|
| DAFNA Capital Management | 895k | $1.4M | 0% | Sep 2024 |
|
| Point72 Asset Management | 894k | $1.4M | 100% | Sep 2024 |
|
| RA Capital Management | 767k | $1.2M | -88% | Sep 2024 |
|
| Opaleye Management | 535k | $840k | -64% | Sep 2024 |
|
| Northern Trust | 497k | $781k | 2666% | Sep 2024 |
|
| CVI Holdings | 401k | $716k | -71% | Jun 2024 |
|
| Victory Capital Management | 399k | $626k | 10% | Sep 2024 |
|
| TD Asset Management | 302k | $486k | 100% | Sep 2024 |
|
| Sarissa Capital Management | 185k | $291k | 0% | Sep 2024 |
|
| Charles Schwab Investment Management | 179k | $281k | 0% | Sep 2024 |
|
| Bank of New York Mellon | 149k | $235k | -24% | Sep 2024 |
|
| Monashee Investment Management | 147k | $231k | -25% | Sep 2024 |
|
| Goldman Sachs Group | 139k | $247k | -39% | Jun 2024 |
|
| Tyche Wealth Partners | 106k | $167k | 921% | Sep 2024 |
|
| Renaissance Technologies | 97k | $153k | -18% | Sep 2024 |
|
| Nuveen Asset Management | 86k | $153k | 100% | Jun 2024 |
|
| Barclays | 85k | $132k | 285% | Sep 2024 |
|
| Jpmorgan Chase & Co | 79k | $124k | 193% | Sep 2024 |
|
| Rhumbline Advisers | 75k | $117k | -3% | Sep 2024 |
|
| Morgan Stanley | 63k | $112k | 126% | Jun 2024 |
|
| Alpine Partners VI | 59k | $105k | 100% | Jun 2024 |
|
| LPL Financial | 58k | $91k | 23% | Sep 2024 |
|
| Bank of America Corporation | 54k | $86k | 65% | Sep 2024 |
|
| Citigroup | 54k | $84k | 279% | Sep 2024 |
|
| New York State Common Retirement Fund | 49k | $78k | 0% | Sep 2024 |
|
| Susquehanna International | 47k | $74k | -66% | Sep 2024 |
|
| American Century Companies | 39k | $61k | 100% | Sep 2024 |
|
| Citadel Advisors | 39k | $61k | 53% | Sep 2024 |
|
| Two Sigma Securities | 39k | $69k | 100% | Jun 2024 |
|
| Two Sigma Investments | 35k | $63k | 100% | Jun 2024 |
|
| Mirae Asset Global Etfs Holdings | 35k | $55k | 100% | Sep 2024 |
|
| AQR Capital Management | 30k | $47k | 100% | Sep 2024 |
|
| Jane Street | 30k | $46k | 100% | Sep 2024 |
|
| Invesco | 28k | $44k | -3% | Sep 2024 |
|
| Alliancebernstein | 27k | $48k | 100% | Jun 2024 |
|
| Wells Fargo & Company | 27k | $42k | 3% | Sep 2024 |
|
| Ing Investment Management | 23k | $36k | 0% | Sep 2024 |
|
| SG Americas Securities | 21k | $33k | 100% | Sep 2024 |
|
| Creative Planning | 17k | $26k | 100% | Sep 2024 |
|
| Wolverine Trading | 14k | $22k | -44% | Sep 2024 |
|
| Commonwealth Equity Services | 12k | $18k | -36% | Sep 2024 |
|
| Grimes & Company | 11k | $17k | 0% | Sep 2024 |
|
| Royal Bank of Canada | 6.2k | $9.1k | 5% | Sep 2024 |
|
| Summit Investment Advisors | 6.2k | $9.7k | 0% | Sep 2024 |
|
| California State Teachers Retirement System | 4.6k | $7.2k | 0% | Sep 2024 |
|
| Amalgamated Bank | 2.2k | $3.0k | 0% | Sep 2024 |
|
| Advisor Group Holdings | 800.00 | $1.3k | 100% | Sep 2024 |
|
| Community Bank | 690.00 | $1.2k | 0% | Jun 2024 |
|
| CWM | 386.00 | $1.0k | 100% | Sep 2024 |
|
| Continuum Advisory | 300.00 | $450.000000 | 100% | Sep 2024 |
|
| Sterling Capital Management | 166.00 | $261.001800 | 100% | Sep 2024 |
|
| Lazard Asset Management | 122.00 | $0 | 0% | Sep 2024 |
|
Who sold out of Regulus Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Soleus Capital Management | Mar 2024 | 1.6M | $4.5M |
| Millennium Management | Jun 2024 | 1.2M | $2.2M |
| Exome Asset Management | Mar 2024 | 403k | $1.2M |
| Hudson Bay Capital Management | Jun 2024 | 250k | $446k |
| Balyasny Asset Management | Mar 2024 | 24k | $70k |
| MetLife Investment Advisors | Jun 2024 | 17k | $30k |
| Simplex Trading | Jun 2024 | 3.6k | $6.0k |
| Tower Research Capital | Mar 2024 | 3.2k | $9.2k |
| Macquarie Group | Mar 2024 | 865.00 | $1.989500 |